VALENZA, CARMINE
VALENZA, CARMINE
Universita' degli Studi di MILANO
Primary malignant phyllodes tumors of the breast: A retrospective analysis from a referral center
2024 C. Valenza, T.M. De Pas, A. Gaeta, G. Castellano, C. Santoro, A. Corona, G. Chiappini, G. Vivanet, D. Trapani, S. Coppola, F. Conforti, D. Mattar, S. Gandini, P. Veronesi, E. Pennacchioli, G. Curigliano
Cardiotoxicity of Agents Used in Patients With Breast Cancer
2024 P. Zagami, D. Trapani, E. Nicolò, C. Corti, C. Valenza, C. Criscitiello, G. Curigliano, L.A. Carey
Biomarkers for antibody-drug conjugates in solid tumors
2024 J. Katrini, L. Boldrini, C. Santoro, C. Valenza, D. Trapani, G. Curigliano
Platinum-based chemotherapy and PARP inhibitors for patients with a germline BRCA pathogenic variant and advanced breast cancer (LATER-BC): retrospective multicentric analysis of post-progression treatments
2023 C. Valenza, D. Trapani, S. Gandini, C. Sposetti, L. Boscolo Bielo, A. Marra, T. Giarratano, D. Favero, L. Cortesi, L. Moscetti, M. Pistelli, R. Berardi, A. Zambelli, M. Lambertini, L. Del Mastro, V. Guarneri, C. Vernieri, G. Curigliano
The immunogram of inflammatory breast cancer
2023 C. Valenza, D. Trapani, N. Fusco, X. Wang, M. Cristofanilli, N.T. Ueno, G. Curigliano
Evolving treatment landscape of immunotherapy in breast cancer: current issues and future perspectives
2023 C. Valenza, G. Rizzo, M.I. Passalacqua, L. Boldrini, C. Corti, D. Trapani, G. Curigliano
Histology-agnostic approvals for antibody-drug conjugates in solid tumours: is the time ripe?
2022 C. Corti, G. Antonarelli, C. Valenza, E. Nicolò, H. Rugo, J. Cortés, N. Harbeck, L.A. Carey, C. Criscitiello, G. Curigliano
Complex differential diagnosis between primary breast cancer and breast metastasis from egfr-mutated lung adenocarcinoma: Case report and literature review
2021 C. Valenza, F.M. Porta, A. Rappa, E. Guerini-Rocco, G. Viale, M. Barberis, F. de Marinis, G. Curigliano, C. Catania